PGR and breast cancer: In case of hormone- or growth factor-dependent breast cancers expressing ER (estrogen receptor), PR (progesterone receptor) and/or epidermal growth factor receptor 2 (HER2) targeted treatment options can significantly increase quality of life and survival.